Genmab A/S | Income Statement
Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
664
850
1,133
1,816
2,365
3,025
SG&A Expense
583
573
547
722
952
1,557
EBIT
69
265
554
1,053
1,366
1,380
Unusual Expense
8
12
29
9
30
-
Non Operating Income/Expense
21
14
196
54
311
169
Interest Expense
-
4
3
4
3
-
Pretax Income
65
297
758
1,130
1,064
1,612
Income Tax
5
4
6
57
40
140
Consolidated Net Income
70
301
764
1,187
1,104
1,472
Net Income
70
301
764
1,187
1,104
1,472
Net Income After Extraordinaries
28
301
764
1,187
1,104
1,472
Net Income Available to Common
60
301
764
1,187
1,104
1,472
EPS (Basic)
2.20
5.35
13.05
19.83
18.14
24.03
Basic Shares Outstanding
51
56
59
60
61
61
EPS (Diluted)
2.16
5.26
12.56
19.22
17.77
23.73
Diluted Shares Outstanding
52
57
61
62
62
62
EBITDA
81
278
586
1,094
1,414
1,468
Non-Operating Interest Income
29
38
37
33
41
63
About Genmab A/S
View Profile
